CNS Pharmaceuticals CNSP Stock
CNS Pharmaceuticals Price Chart
CNS Pharmaceuticals CNSP Financial and Trading Overview
| CNS Pharmaceuticals stock price | 5.24 USD |
| Previous Close | 5.44 USD |
| Open | 5.15 USD |
| Bid | 3.69 USD x 200 |
| Ask | 6.41 USD x 200 |
| Day's Range | 4.97 - 5.15 USD |
| 52 Week Range | 1.9 - 12.96 USD |
| Volume | 17.43K USD |
| Avg. Volume | 1.42M USD |
| Market Cap | 7.35M USD |
| Beta (5Y Monthly) | 0.54 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -24.12 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10 USD |
CNSP Valuation Measures
| Enterprise Value | 4.63M USD |
| Trailing P/E | N/A |
| Forward P/E | -12.897437 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 57.816097 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.279 |
Trading Information
CNS Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.54 |
| 52-Week Change | -58.49% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 12.96 USD |
| 52 Week Low | 1.9 USD |
| 50-Day Moving Average | 3.76 USD |
| 200-Day Moving Average | 5.69 USD |
CNSP Share Statistics
| Avg. Volume (3 month) | 1.42M USD |
| Avg. Daily Volume (10-Days) | 125.83K USD |
| Shares Outstanding | 1.46M |
| Float | 1.45M |
| Short Ratio | 0.01 |
| % Held by Insiders | 0.55% |
| % Held by Institutions | 12.02% |
| Shares Short | 30.58K |
| Short % of Float | 2.10% |
| Short % of Shares Outstanding | 2.08% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -112.92% |
| Return on Equity (ttm) | -298.64% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -16619418 USD |
| Net Income Avi to Common (ttm) | -16486290 USD |
| Diluted EPS (ttm) | -24.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.95M USD |
| Total Cash Per Share (mrq) | 2.02 USD |
| Total Debt (mrq) | 232.35K USD |
| Total Debt/Equity (mrq) | 328.62 USD |
| Current Ratio (mrq) | 0.89 |
| Book Value Per Share (mrq) | 0.087 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15217818 USD |
| Levered Free Cash Flow (ttm) | -8962689 USD |
Profile of CNS Pharmaceuticals
| Country | United States |
| State | TX |
| City | Houston |
| Address | 2100 West Loop South |
| ZIP | 77027 |
| Phone | 800 946 9185 |
| Website | https://cnspharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Q&A For CNS Pharmaceuticals Stock
What is a current CNSP stock price?
CNS Pharmaceuticals CNSP stock price today per share is 5.24 USD.
How to purchase CNS Pharmaceuticals stock?
You can buy CNSP shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CNS Pharmaceuticals?
The stock symbol or ticker of CNS Pharmaceuticals is CNSP.
Which industry does the CNS Pharmaceuticals company belong to?
The CNS Pharmaceuticals industry is Biotechnology.
How many shares does CNS Pharmaceuticals have in circulation?
The max supply of CNS Pharmaceuticals shares is 1.46M.
What is CNS Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
CNS Pharmaceuticals PE Ratio is now.
What was CNS Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
CNS Pharmaceuticals EPS is -24.12 USD over the trailing 12 months.
Which sector does the CNS Pharmaceuticals company belong to?
The CNS Pharmaceuticals sector is Healthcare.
CNS Pharmaceuticals CNSP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Capital Market Composite RCMP | 148.96 USD — |
-1.84
|
— — | 148.23 USD — | 151.02 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}